Kissei Pharmaceutical Co., Ltd. (TYO:4547)
Japan · Delayed Price · Currency is JPY 3,885.00
+55.00 (1.44%)
Nov 13, 2026, 3:30 PM JST
Kissei Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 11,186 | 16,891 | 15,610 | 14,449 | 13,680 | 16,507 |
Depreciation & Amortization | 4,765 | 4,644 | 4,615 | 4,254 | 4,109 | 3,730 |
Loss (Gain) From Sale of Assets | -822 | -701 | 3,110 | -80 | -63 | 35 |
Loss (Gain) From Sale of Investments | -10,672 | -17,376 | -11,999 | -9,119 | -13,133 | -16,161 |
Other Operating Activities | -1,869 | -3,061 | -4,427 | -1,893 | -5,799 | -2,672 |
Change in Accounts Receivable | -1,187 | -1,929 | -974 | -5,863 | 27 | 250 |
Change in Inventory | 238 | -542 | 1,316 | -3,480 | -3,810 | 1,130 |
Change in Accounts Payable | -2,462 | 2,059 | -291 | 275 | 513 | -3,804 |
Change in Other Net Operating Assets | -10,944 | -1,470 | -439 | -220 | -2,203 | 2,518 |
Operating Cash Flow | -8,945 | -1,485 | 6,521 | -1,677 | -6,679 | 1,533 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -4,473 | -4,883 | -4,507 | -1,201 | -2,103 | -1,489 |
Sale of Property, Plant & Equipment | 3,443 | 3,379 | 519 | 175 | 78 | 23 |
Sale (Purchase) of Intangibles | -678 | -753 | -523 | -632 | -444 | -430 |
Investment in Securities | 9,930 | 19,943 | 13,091 | 9,502 | 13,031 | 16,391 |
Other Investing Activities | 483 | -188 | -3,627 | 844 | -4,564 | -3,741 |
Investing Cash Flow | 8,708 | 17,500 | 4,952 | 8,690 | 6,001 | 10,776 |
Financing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | 170 | 170 | - | - | - |
Total Debt Issued | 170 | 170 | 170 | - | - | - |
Short-Term Debt Repaid | - | -200 | -230 | -150 | -150 | -90 |
Long-Term Debt Repaid | - | - | - | - | - | -13 |
Total Debt Repaid | -329 | -200 | -230 | -150 | -150 | -103 |
Net Debt Issued (Repaid) | -159 | -30 | -60 | -150 | -150 | -103 |
Repurchase of Common Stock | -731 | -5,217 | -5,293 | -6,000 | - | - |
Common Dividends Paid | -6,632 | -4,841 | -3,801 | -3,722 | -3,135 | -2,536 |
Other Financing Activities | -1 | -167 | -171 | -134 | -135 | -117 |
Financing Cash Flow | -7,523 | -10,255 | -9,325 | -10,006 | -3,420 | -2,756 |
Net Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Foreign Exchange Rate Adjustments | 33 | 52 | 27 | -3 | -21 | 4 |
Miscellaneous Cash Flow Adjustments | -1 | - | 96 | -1 | -1 | - |
Net Cash Flow | -7,728 | 5,812 | 2,271 | -2,997 | -4,120 | 9,557 |
Free Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -13,418 | -6,368 | 2,014 | -2,878 | -8,782 | 44 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -13.82% | -6.54% | 2.28% | -3.81% | -13.01% | 0.07% |
Free Cash Flow Per Share | -323.25 | -153.22 | 46.17 | -63.59 | -190.44 | 0.95 |
Levered Free Cash Flow | -12,800 | 82.75 | 2,448 | 200.38 | -7,654 | 3,843 |
Unlevered Free Cash Flow | -12,778 | 100.25 | 2,461 | 211.63 | -7,641 | 3,858 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 35 | 29 | 22 | 18 | 20 | 23 |
Cash Income Tax Paid | 6,864 | 3,363 | 4,357 | 1,834 | 5,699 | 2,567 |
Change in Working Capital | -13,695 | -1,882 | -388 | -9,288 | -5,473 | 94 |